C18ORF25 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.457700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.490600E-01
Normal-vs-Stage2
6.505500E-02
Normal-vs-Stage3
4.144000E-02
Normal-vs-Stage4
3.917000E-01
Stage1-vs-Stage2
3.611800E-01
Stage1-vs-Stage3
7.024300E-02
Stage1-vs-Stage4
7.648400E-01
Stage2-vs-Stage3
7.542200E-02
Stage2-vs-Stage4
7.764600E-01
Stage3-vs-Stage4
1.596840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.900100E-02
Normal-vs-AfricanAmerican
4.312000E-01
Normal-vs-Asian
1.785630E-02
Caucasian-vs-AfricanAmerican
4.410000E-01
Caucasian-vs-Asian
2.182500E-02
AfricanAmerican-vs-Asian
5.066400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.086200E-02
Normal-vs-Female
1.480620E-01
Male-vs-Female
1.457010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.326200E-01
Normal-vs-Age(41-60Yrs)
2.686800E-01
Normal-vs-Age(61-80Yrs)
3.720200E-02
Normal-vs-Age(81-100Yrs)
6.589600E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.856800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.997800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.980400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.644080E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.949700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.991400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.497960E-02
Normal-vs-Daily Drinker
1.251940E-02
Normal-vs-Weekly Drinker
4.630000E-02
Normal-vs-Occasional Drinker
2.302400E-01
Normal-vs-Social Drinker
4.785200E-01
Non Drinker-vs-Daily Drinker
5.242600E-01
Non Drinker-vs-Weekly Drinker
8.411800E-01
Non Drinker-vs-Occasional Drinker
1.882320E-02
Non Drinker-vs-Social Drinker
6.427800E-02
Daily Drinker-vs-Weekly Drinker
7.591000E-01
Daily Drinker-vs-Occasional Drinker
8.038000E-03
Daily Drinker-vs-Social Drinker
1.756150E-02
Weekly Drinker-vs-Occasional Drinker
4.776300E-02
Weekly Drinker-vs-Social Drinker
7.692000E-02
Occasional Drinker-vs-Social Drinker
7.528800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.702610E-01
Normal-vs-Grade 2
3.780200E-02
Normal-vs-Grade 3
1.557870E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.202800E-01
Grade 1-vs-Grade 3
9.026000E-01
Grade 1-vs-Grade 4
1.702610E-01
Grade 2-vs-Grade 3
6.746400E-01
Grade 2-vs-Grade 4
3.780200E-02
Grade 3-vs-Grade 4
1.557870E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.884400E-02
Normal-vs-NonDiabetic
3.878100E-02
Diabetic-vs-NonDiabetic
6.272600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.752430E-02
Normal-vs-NoPancreatitis
3.898000E-02
Pancreatitis-vs-NoPancreatitis
4.231200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.619200E-01
Normal-vs-N1
5.618200E-02
N0-vs-N1
8.219400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.699500E-02
Normal-vs-TP53-NonMutant
3.403400E-01
TP53-Mutant-vs-TP53-NonMutant
3.905800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
